Atlas FDA

INTERSTIM THERAPY SYSTEM (URINARY)

FDA premarket approval P970004/S222 · decided 2016-08-22

Approval details

PMA number
P970004
Supplement
S222
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
INTERSTIM THERAPY SYSTEM (URINARY)
Generic name
Stimulator, electrical, implantable, for incontinence
Applicant
Medtronic Neuromodulation
Date received
2016-07-25
Decision date
2016-08-22
Days to decision
28 days
Decision code
OK30
Product code
EZW
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Minneapolis, MN
Statement
Changes to the manufacturing execution system (FACTORYworks) for Business Rule Client 9.2, Configuration Client 9.2, and Integrated Manufacturing Process Management Web Services 3.1.0.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
SureTune4 Software (DEN210003)Medtronic Neuromodulation2021-08-23